HELP Committee Leaders Aim To Prevent Controversial Add-Ons To User Fee Bill

Members of the Senate HELP Committee expressed concerns that potential riders added to the FDA user fee bill could slow down passage and add more work for FDA staff.

Senators called for Congress to reauthorize FDA user fees quickly and avoid adding any controversial proposals that might slow down passage during a Senate Health, Education, Labor and Pensions Committee hearing March 29.

Committee Chairman Tom Harkin, D-Iowa, congratulated FDA and industry for crafting a “win-win agreement” to reauthorize user fees for medical...

More from Legislation

More from Policy & Regulation